Adrenoleukodystrophy: Clinical Trials

12 trials for Adrenoleukodystrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 12 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 6, Recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1

Follow Adrenoleukodystrophy: new trials by email Literature Review of Adrenoleukodystrophy trials Research Report on Adrenoleukodystrophy

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IT and IV Lentiviral Gene Therapy for X-ALD
Intrathecal and intravenous LV gene therapy - X-linked Adrenoleukodystrophy
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute302027-06-012026-11-02
Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
Spinal cord stimulation - Adrenomyeloneuropathy Without Cerebral Involvement
Not applicableRecruitingThird Military Medical University102025-02-102025-01-28
Home Exercise for Individuals With Neurodegenerative Disease
Home exercise - Neurodegenerative Diseases, Leukodystrophy
Not applicableRecruitingHugo W. Moser Research Institute at Kennedy Krieger, Inc.302023-02-132026-09-16
SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)
SMART-ALD, Waiting list - X-linked Adrenoleukodystrophy
Not applicableCompletedLeipzig University Medical Center682022-05-202024-03-13
Precision Exercise in Children With Malignant Hemopathies
Sport Therapy - Leukemia, Myeloid, Acute, Leukemia, B-cell
Not applicableUnknownUniversity of Milano Bicocca3802017-04-032024-01-02
Repetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneuropathy
rTMS - Hereditary Spastic Paraplegia, Adrenomyeloneuropathy
Not applicableCompletedJakub Antczak152017-01-092021-09-27
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
Campath-1H, Clofarabine, Melphalan - Lysosomal Storage Disease, Peroxisomal Disorder
Not applicableCompletedMasonic Cancer Center, University of Minnesota32012-07-112017-12-05
Exercise Study of Function and Pathology for Women With X-linked Adrenoleukodystrophy
exercise training - X-linked Adrenoleukodystrophy
Not applicableCompletedHugo W. Moser Research Institute at Kennedy Krieger, Inc.312012-05-012018-08-29
The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)
Bezafibrate - X-linked Adrenoleukodystrophy, Adrenomyeloneuropathy
Not applicableCompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)102010-07-012011-08-10
Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children
blood sampling and medical records - Adrenoleukodystrophy
Not applicableUnknownFar Eastern Memorial Hospital202006-01-012009-02-09
Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy
glyceryl trierucate, glyceryl trioleate, interferon beta - Adrenoleukodystrophy
Not applicableCompletedFDA Office of Orphan Products Development601998-08-012015-03-25
Study of Bile Acids in Patients With Peroxisomal Disorders
chenodeoxycholic acid, cholic acid, ursodiol - Infantile Refsum's Disease, Zellweger Syndrome
Not applicableTerminatedUniversity of Cincinnati252015-03-25

Narrower conditions

Peroxisomal Disorders (3)  ·  Rare Diseases (3)  ·  Metabolism, Inborn Errors (2)  ·  Motor Activity (2)  ·  Sphingolipidoses (2)  ·  Ataxia (1)  ·  Central Nervous System Diseases (1)  ·  Cerebellar Ataxia (1)  ·  Gangliosidosis, GM1 (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Leukemia, B-Cell (1)

Broader conditions

Adrenal Gland Diseases (12)  ·  Adrenal Insufficiency (12)  ·  Brain Diseases (12)  ·  Brain Diseases, Metabolic (12)  ·  Brain Diseases, Metabolic, Inborn (12)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Demyelinating Diseases (12)  ·  Endocrine System Diseases (12)  ·  Hereditary Central Nervous System Demyelinating Diseases (12)  ·  Heredodegenerative Disorders, Nervous System (12)  ·  Intellectual Disability (12)  ·  Leukoencephalopathies (12)  ·  Metabolic Diseases (12)  ·  Nervous System Diseases (12)  ·  Neurobehavioral Manifestations (12)

Interventions

Alemtuzumab (1)  ·  Bezafibrate (1)  ·  Blood Specimen Collection (1)  ·  Chenodeoxycholic Acid (1)  ·  Cholic Acid (1)  ·  Clofarabine (1)  ·  Cyclosporine (1)  ·  Exercise (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Interferon-beta (1)  ·  Medical Records (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Resistance Training (1)

Sponsors

Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  FDA Office of Orphan Products Development (1)  ·  Far Eastern Memorial Hospital (1)  ·  Jakub Antczak (1)  ·  Leipzig University Medical Center (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Shenzhen Geno-Immune Medical Institute (1)  ·  Third Military Medical University (1)  ·  University of Cincinnati (1)  ·  University of Milano Bicocca (1)

Countries

United States (3)  ·  China (2)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Taiwan (1)

Top investigators

Andrea Biondi, MD, PhD (1)  ·  Hugo Wolfgang Moser (1)  ·  Jakub M Antczak, MD (1)  ·  Jao Shwann Liang, MD (1)  ·  Jennifer Keller, PT (1)  ·  Kathleen M Zackowski, Ph.D. (1)  ·  Kenneth Setchell (1)  ·  Weston Miller, MD (1)

Results publications

PMID 19833552, PMID 22911730, PMID 31214256, PMID 41030609